vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and UNITED FIRE GROUP INC (UFCS). Click either name above to swap in a different company.

UNITED FIRE GROUP INC is the larger business by last-quarter revenue ($365.8M vs $202.1M, roughly 1.8× CORCEPT THERAPEUTICS INC). On growth, CORCEPT THERAPEUTICS INC posted the faster year-over-year revenue change (11.1% vs 9.8%). Over the past eight quarters, CORCEPT THERAPEUTICS INC's revenue compounded faster (17.3% CAGR vs 11.2%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

The United Fruit Company was an American multinational corporation that traded in tropical fruit grown on Latin American plantations and sold in the United States and Europe. The company was formed in 1899 from the merger of the Boston Fruit Company with Minor C. Keith's banana-trading enterprises. It flourished in the early and mid-20th century, and it came to control vast territories and transportation networks in Central America, the Caribbean coast of Colombia, and the West Indies. Althou...

CORT vs UFCS — Head-to-Head

Bigger by revenue
UFCS
UFCS
1.8× larger
UFCS
$365.8M
$202.1M
CORT
Growing faster (revenue YoY)
CORT
CORT
+1.3% gap
CORT
11.1%
9.8%
UFCS
Faster 2-yr revenue CAGR
CORT
CORT
Annualised
CORT
17.3%
11.2%
UFCS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CORT
CORT
UFCS
UFCS
Revenue
$202.1M
$365.8M
Net Profit
$24.3M
Gross Margin
98.7%
Operating Margin
2.2%
13.2%
Net Margin
12.0%
Revenue YoY
11.1%
9.8%
Net Profit YoY
-21.0%
EPS (diluted)
$0.20
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
UFCS
UFCS
Q4 25
$202.1M
$365.8M
Q3 25
$207.6M
$354.0M
Q2 25
$194.4M
$335.5M
Q1 25
$157.2M
$331.1M
Q4 24
$181.9M
$333.2M
Q3 24
$182.5M
$323.0M
Q2 24
$163.8M
$301.2M
Q1 24
$146.8M
$296.0M
Net Profit
CORT
CORT
UFCS
UFCS
Q4 25
$24.3M
Q3 25
$19.7M
$39.2M
Q2 25
$35.1M
$22.9M
Q1 25
$20.5M
$17.7M
Q4 24
$30.7M
Q3 24
$47.2M
$19.7M
Q2 24
$35.5M
$-2.7M
Q1 24
$27.8M
$13.5M
Gross Margin
CORT
CORT
UFCS
UFCS
Q4 25
98.7%
Q3 25
97.8%
Q2 25
98.2%
Q1 25
98.5%
Q4 24
98.4%
Q3 24
98.4%
Q2 24
98.5%
Q1 24
98.3%
Operating Margin
CORT
CORT
UFCS
UFCS
Q4 25
2.2%
13.2%
Q3 25
4.9%
13.7%
Q2 25
13.7%
8.7%
Q1 25
2.2%
6.6%
Q4 24
13.9%
11.9%
Q3 24
25.5%
7.7%
Q2 24
21.7%
-1.3%
Q1 24
20.1%
5.5%
Net Margin
CORT
CORT
UFCS
UFCS
Q4 25
12.0%
Q3 25
9.5%
11.1%
Q2 25
18.1%
6.8%
Q1 25
13.1%
5.3%
Q4 24
16.9%
Q3 24
25.9%
6.1%
Q2 24
21.7%
-0.9%
Q1 24
18.9%
4.6%
EPS (diluted)
CORT
CORT
UFCS
UFCS
Q4 25
$0.20
$1.45
Q3 25
$0.16
$1.49
Q2 25
$0.29
$0.87
Q1 25
$0.17
$0.67
Q4 24
$0.25
$1.22
Q3 24
$0.41
$0.76
Q2 24
$0.32
$-0.11
Q1 24
$0.25
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
UFCS
UFCS
Cash + ST InvestmentsLiquidity on hand
$372.2M
$156.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$647.8M
$941.2M
Total Assets
$836.7M
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
UFCS
UFCS
Q4 25
$372.2M
$156.3M
Q3 25
$421.7M
$233.7M
Q2 25
$342.2M
$202.1M
Q1 25
$322.8M
$183.7M
Q4 24
$383.3M
$200.9M
Q3 24
$380.3M
$197.4M
Q2 24
$473.2M
$153.4M
Q1 24
$410.8M
$217.8M
Stockholders' Equity
CORT
CORT
UFCS
UFCS
Q4 25
$647.8M
$941.2M
Q3 25
$631.9M
$898.7M
Q2 25
$635.8M
$845.7M
Q1 25
$683.3M
$817.7M
Q4 24
$679.6M
$781.5M
Q3 24
$638.8M
$785.8M
Q2 24
$596.2M
$726.6M
Q1 24
$547.9M
$736.8M
Total Assets
CORT
CORT
UFCS
UFCS
Q4 25
$836.7M
$3.8B
Q3 25
$823.6M
$3.8B
Q2 25
$801.7M
$3.7B
Q1 25
$846.5M
$3.5B
Q4 24
$840.6M
$3.5B
Q3 24
$784.3M
$3.5B
Q2 24
$714.6M
$3.4B
Q1 24
$655.9M
$3.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
UFCS
UFCS
Operating Cash FlowLast quarter
$38.4M
$269.7M
Free Cash FlowOCF − Capex
$38.4M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.58×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
UFCS
UFCS
Q4 25
$38.4M
$269.7M
Q3 25
$54.5M
$60.8M
Q2 25
$43.9M
$53.4M
Q1 25
$5.1M
$35.7M
Q4 24
$59.3M
$340.3M
Q3 24
$73.8M
$56.5M
Q2 24
$41.2M
$91.3M
Q1 24
$23.8M
$36.2M
Free Cash Flow
CORT
CORT
UFCS
UFCS
Q4 25
$38.4M
Q3 25
Q2 25
$43.9M
Q1 25
$5.0M
Q4 24
$59.2M
Q3 24
$72.2M
Q2 24
$40.8M
Q1 24
FCF Margin
CORT
CORT
UFCS
UFCS
Q4 25
19.0%
Q3 25
Q2 25
22.6%
Q1 25
3.2%
Q4 24
32.5%
Q3 24
39.5%
Q2 24
24.9%
Q1 24
Capex Intensity
CORT
CORT
UFCS
UFCS
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.9%
Q2 24
0.3%
Q1 24
0.0%
Cash Conversion
CORT
CORT
UFCS
UFCS
Q4 25
1.58×
Q3 25
2.77×
1.55×
Q2 25
1.25×
2.33×
Q1 25
0.25×
2.02×
Q4 24
1.93×
Q3 24
1.56×
2.86×
Q2 24
1.16×
Q1 24
0.86×
2.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons